These compounds may interact with:
MAP kinase-activated protein kinase 2
Potentially involved in: carcinoma; atypical teratoid / rhabdoid tumor; breast carcinoma; copd; dermatomyositis; ependymoma; glioblastoma; invasive ductal carcinoma; medulloblastoma; medulloblastoma, large-cell; osteosarcoma; pediatric high grade glioma; pilocytic astrocytoma; pituitary cancer; primitive neuroectodermal tumor; psoriasis; ulcerative colitis
Disease data sourced from Pharos.